Morihiro Higashi, Shuji Momose, Natsuko Takayanagi, Yuka Tanaka, Tomoe Anan, Takahisa Yamashita, Jun Kikuchi, Michihide Tokuhira, Masahiro Kizaki, Jun-Ichi Tamaru. CD24 is a surrogate for “immune-cold” phenotype in aggressive large B-cell lymphoma. The Journal of Pathology. 2022. 8. 4. 340-354
Yuka Tanaka, Shuji Momose, Natsuko Takayanagi, Takayuki Tabayashi, Michihide Tokuhira, Jun-ichi Tamaru, Masahiro Kizaki. Rapid deterioration of intravascular large B-cell lymphoma with mass formation in the trigeminal nerve and multiple organ infiltration: An autopsy case report. Journal of Clinical and Experimental Hematopathology. 2022. 62. 1. 41-45
Morihiro Higashi, Jun Kikuchi, Chiaki Murakami, Natsuko Takayanagi, Shuji Momose, Masahiro Kizaki, Jun-ichi Tamaru. Better method for detection of CD30: Immunohistochemistry or flow cytometry?. Journal of Clinical and Experimental Hematopathology. 2021. 61. 4. 221-223
Natsuko Takayanagi, Shuji Momose, Jun Kikuchi, Yuka Tanaka, Tomoe Anan, Takahisa Yamashita, Morihiro Higashi, Michihide Tokuhira, Masahiro Kizaki, Jun-ichi Tamaru. Fluorescent nanoparticle-mediated semiquantitative MYC protein expression analysis in morphologically diffuse large B-cell lymphoma. Pathology International. 2021. 71. 9. 594-603
講演・口頭発表等 (2件)：
DLBCL における CD24 分子発現の役割
(第110回日本病理学会総会 2021)
Decreased MYC-associated factor X (MAX) expression is a new potential biomarker for adverse prognosis in anaplastic large cell lymphoma
(第60回 日本リンパ網内系学会総会 2020)
